PROLOPA CAP 200-50
Active Ingredient: LEVODOPA, BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)
Product Overview
About PROLOPA CAP 200-50
PROLOPA CAP 200-50 is a prescription medication designed to treat Parkinson's disease and other conditions associated with dopamine deficiency. This medication is a combination of two active ingredients: Levodopa and Benserazide (Benserazide Hydrochloride). Levodopa is converted into dopamine in the brain, helping to alleviate symptoms of Parkinson's disease, while Benserazide inhibits the enzyme DOPA decarboxylase, allowing more Levodopa to reach the brain.
Key Benefits & Uses
- Treatment of Parkinson's disease symptoms, including tremors, stiffness, and difficulty with movement.
- Relief from symptoms of dopamine deficiency, such as fatigue, depression, and anxiety.
- Improvement in motor function and quality of life for patients with Parkinson's disease.
Active Ingredient & Action
LEVODOPA is an amino acid that is converted into dopamine in the brain, where it acts as a neurotransmitter to regulate movement and other functions. BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE) is a decarboxylase inhibitor that prevents the breakdown of Levodopa, allowing more of it to reach the brain and be converted into dopamine.
Important Notes
PROLOPA CAP 200-50 should only be used under the guidance of a qualified healthcare professional. It is essential to follow the prescribed dosage and usage instructions carefully. Common side effects may include nausea, vomiting, and dizziness. Patients with a history of heart disease or high blood pressure should use this medication with caution. Consult your doctor or pharmacist for more information and to discuss any concerns.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
